| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-07 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |